Chilton Investment Co. Inc. Acquires Shares of 7,670 Colgate-Palmolive Company $CL

Chilton Investment Co. Inc. acquired a new position in Colgate-Palmolive Company (NYSE:CL) in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 7,670 shares of the company’s stock, valued at approximately $613,000.

Other hedge funds have also recently made changes to their positions in the company. Vermillion & White Wealth Management Group LLC lifted its holdings in shares of Colgate-Palmolive by 86.1% in the 2nd quarter. Vermillion & White Wealth Management Group LLC now owns 335 shares of the company’s stock valued at $30,000 after acquiring an additional 155 shares during the last quarter. Copia Wealth Management bought a new stake in Colgate-Palmolive during the third quarter worth approximately $29,000. Cloud Capital Management LLC bought a new stake in Colgate-Palmolive during the third quarter worth approximately $30,000. MTM Investment Management LLC purchased a new stake in Colgate-Palmolive during the second quarter valued at approximately $39,000. Finally, Kelleher Financial Advisors purchased a new stake in Colgate-Palmolive during the third quarter valued at approximately $35,000. 80.41% of the stock is currently owned by hedge funds and other institutional investors.

Colgate-Palmolive Trading Up 1.0%

Shares of NYSE CL opened at $88.85 on Monday. Colgate-Palmolive Company has a fifty-two week low of $74.54 and a fifty-two week high of $99.33. The company has a debt-to-equity ratio of 18.82, a quick ratio of 0.54 and a current ratio of 0.83. The company has a market cap of $71.62 billion, a price-to-earnings ratio of 33.91, a PEG ratio of 3.98 and a beta of 0.28. The business’s 50 day moving average price is $90.11 and its 200-day moving average price is $83.22.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, January 30th. The company reported $0.95 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.91 by $0.04. The company had revenue of $5.23 billion during the quarter, compared to analysts’ expectations of $5.13 billion. Colgate-Palmolive had a return on equity of 353.72% and a net margin of 10.45%.Colgate-Palmolive’s revenue was up 5.8% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.91 EPS. On average, sell-side analysts expect that Colgate-Palmolive Company will post 3.75 earnings per share for the current year.

Colgate-Palmolive Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Stockholders of record on Monday, April 20th will be paid a dividend of $0.53 per share. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.52. This represents a $2.12 dividend on an annualized basis and a dividend yield of 2.4%. The ex-dividend date of this dividend is Monday, April 20th. Colgate-Palmolive’s payout ratio is presently 79.39%.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on the company. UBS Group lifted their target price on Colgate-Palmolive from $90.00 to $93.00 and gave the stock a “buy” rating in a report on Wednesday, January 14th. Weiss Ratings restated a “hold (c)” rating on shares of Colgate-Palmolive in a report on Wednesday, January 21st. Deutsche Bank Aktiengesellschaft raised their price target on Colgate-Palmolive from $83.00 to $90.00 and gave the stock a “hold” rating in a research report on Monday, February 2nd. Piper Sandler boosted their price objective on shares of Colgate-Palmolive from $88.00 to $96.00 and gave the company an “overweight” rating in a research report on Friday, January 30th. Finally, Barclays increased their target price on shares of Colgate-Palmolive from $83.00 to $88.00 and gave the company an “equal weight” rating in a research note on Tuesday, February 3rd. Eleven research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $94.75.

Insider Activity at Colgate-Palmolive

In other Colgate-Palmolive news, COO Panagiotis Tsourapas sold 35,000 shares of the business’s stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $94.61, for a total value of $3,311,350.00. Following the completion of the sale, the chief operating officer directly owned 10,415 shares of the company’s stock, valued at $985,363.15. The trade was a 77.07% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider John Hazlin sold 20,989 shares of the company’s stock in a transaction dated Tuesday, February 10th. The stock was sold at an average price of $94.25, for a total transaction of $1,978,213.25. Following the completion of the transaction, the insider owned 17,645 shares in the company, valued at $1,663,041.25. This represents a 54.33% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last three months, insiders have sold 184,683 shares of company stock valued at $17,486,693. Company insiders own 0.41% of the company’s stock.

About Colgate-Palmolive

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.